concentrations
[용어속성] abnormalities
Airborne Disinfection by Dry Fogging Efficiently Inactivates Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Mycobacteria, and Bacterial Spores and Shows Limitations of Commercial Spore Carriers
Environmental Microbiology
[키워드] Geobacillus stearothermophilus
Mycobacterium senegalense
acute respiratory syndrome
addition
airborne disinfection
Bacillus subtilis
can be used
carrier
coated with
Community
complex
Concentration
concentrations
coronavirus
coronavirus 2
determine
develop
Disinfection
Dry
dry fog
effective
Efficacy
fogging
Hospital wards
hydrogen peroxide
inactivated
inactivation
Indiana vesiculovirus (VSIV)
infectious agent
Laboratory
limitation
methodology
microorganism
microorganisms
Murine norovirus (MNV)
mycobacteria
Neutral
pandemic
parameter
peroxyacetic acid
protocol
public health emergency
Quantitative
reduction
respiratory
robust
room disinfection
Safe
SARS-CoV-2
SARS-CoV-2 pandemic
sensitivity
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
show
spore
spores
temperature
tested
viral pathogen
virus
viruses
[DOI] 10.1128/AEM.02019-20 PMC 바로가기 [Article Type] Environmental Microbiology
[DOI] 10.1128/AEM.02019-20 PMC 바로가기 [Article Type] Environmental Microbiology
CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS
Research
[키워드] acute respiratory distress syndrome
alarmin
alveolar
alveolar cell
ARDS
ARDS patients
Biomarker
Bronchoalveolar lavage
CCL5
CD40 ligand
cell-free mitochondrial DNA
clinical
Concentration
concentrations
confounders
correlated
correlation
COVID-19
COVID-19 ARDS patient
COVID-19 ARDS patients
CXCL-10
CXCL1
CXCL10
CXCL2
DNA
dysregulated immune response
EGF
elevated
epithelial lining
etiology
evaluated
feature
GM-CSF
granzyme B
host response
IL-10
IL-1β
IL-8
immune response
Inflammatory
inflammatory mediator
involved
lung
mechanical ventilation
mitochondrial
mitochondrial DNA
no difference
Non-COVID-19
outcome
Pathogenesis
plasma
predict
required
Result
SARS-CoV-2
significantly
systemic inflammation
targeting
Therapeutic approach
TRAIL
two groups
unique
Ventilator-free days
Viral load
were measured
[DOI] 10.1186/s13054-020-03328-0 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13054-020-03328-0 PMC 바로가기 [Article Type] Research
Association of particulate matter pollution and case fatality rate of COVID-19 in 49 Chinese cities
Article
[키워드] Abstract
Affect
Analysis
association
autocorrelation
caused
CFR
CFRs
China
Chinese
Clustering
Concentration
concentrations
COVID-19
COVID-19 epidemic
COVID-19 prognosis
cross-sectional study
death
death rate
distribution
Fatality rate
Image
increase in
Linear regression
Particulate matter
Particulate matter pollution
positive
Result
suggested
the SARS-CoV-2 virus
with COVID-19
Wuhan
[DOI] 10.1016/j.scitotenv.2020.140396 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.scitotenv.2020.140396 PMC 바로가기 [Article Type] Article
Evidence Regarding Vitamin D and Risk of COVID-19 and Its Severity
Review
[키워드] 25-hydroxyvitamin D
age
angiotensin-converting enzyme 2
association
Cathelicidin
cells
Concentration
concentrations
correlated
COVID
COVID-19
criteria
deficiency
disease
Endothelial dysfunction
endothelial integrity
Evidence
feature
IL-6
illness
immune system
incidence
Inflammation
inflammatory cytokine production
Interaction
mechanisms
MMP-9
observational study
offer
patients with COVID-19
physician
Prevent
public health
Randomized controlled trial
reduce
reducing
Replication
required
respiratory tract infection
risk
SARS-CoV-2
serum 25-hydroxyvitamin D
severity of COVID-19
survival
therapeutic window
treat
viruses
Vitamin D
vitamin D deficiency
vitamin D supplement
[DOI] 10.3390/nu12113361 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/nu12113361 PMC 바로가기 [Article Type] Review
Inhibition of Porcine Epidemic Diarrhea Virus Replication and Viral 3C-Like Protease by Quercetin
Article
[키워드] 3C-like protease
3CL pro
Analysis
Antiviral
binding affinity
binding pocket
caused
concentrations
coronavirus
drug target
effective
energy transfer
epidemic diarrhea
exhibited
indicated
Infection
inhibition
inhibitory effect
molecular docking
PEDV
Porcine epidemic diarrhea virus
protease
quercetin
significantly
SPR
strain
suppressed
surface plasmon resonance
Therapeutic treatment
variant
viral replication
virus
[DOI] 10.3390/ijms21218095 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/ijms21218095 PMC 바로가기 [Article Type] Article
Aprotinin Inhibits SARS-CoV-2 Replication
아프로티닌은 SARS-CoV-2 복제를 억제합니다
Article
[키워드] 2019-nCoV
acute respiratory syndrome
air–liquid interface
Alpha
Analysis
Anti-SARS-CoV-2 Activity
Antiviral
approved
Aprotinin
Caco2
Calu
Calu-3
Cell
cell type
cell types
cellular proteases
cleavage
Concentration
concentrations
coronavirus
coronavirus disease
COVID-19
COVID-19 progression
cultures
disease
downregulated
downregulation
Drug discovery
epithelial
epithelial cell
host cell
host cell protease
host cell proteases
indicated
inhibited
inhibitor
isolates
Local
local control
pandemic
Prevent
prevention of COVID-19
progression
Protease inhibitor
protease inhibitors
Protein
proteomics
respiratory
SARS-CoV-2
SARS-CoV-2 replication
SERPINA1
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
severe acute respiratory syndrome virus
systemic disease
therapeutic
virus
virus entry
virus replication
[DOI] 10.3390/cells9112377 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/cells9112377 PMC 바로가기 [Article Type] Article
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Research Article
[키워드] acute respiratory syndrome
adaptive immune responses
Adults
age
Anti-spike
Antibody titer
Antibody-dependent cellular phagocytosis
antiviral immune response
caused
CD25
CD4
Cellular immune response
children
circulating
clinical manifestation
clinical outcomes
Concentration
concentrations
coronavirus
coronavirus disease
correlated
COVID-19
cytokine
described
difference
disease
evidenced
Factor
Frequency
generate
hospital
Hospitalization
Hospitalized
human coronaviruses
humoral
identify
IFN-γ
IL-17A
IL-6
immune response
increased expression
Inflammatory
interferon-γ
interleukin-17A
lower mortality
mechanical ventilation
mechanisms
modulate
Mortality
mounted
Necrosis
Neutralizing antibody titer
New York City
no difference
outcome
Patient
patients with COVID-19
pediatric
Pediatric patient
people with COVID-19
Pierce
Protein
response
robust
SARS-CoV-2
SARS-COV-2 infection
serum
Serum neutralizing antibody
syndrome
T cell
T cell response
T cells
TNF-α
viral spike protein
with COVID-19
younger patients
[DOI] 10.1126/scitranslmed.abd5487 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1126/scitranslmed.abd5487 PMC 바로가기 [Article Type] Research Article
Cholesterol 25‐Hydroxylase inhibits SARS ‐CoV‐2 and other coronaviruses by depleting membrane cholesterol
Article
[키워드] COVID ‐19 treatment
activating
Activation
Antiviral
antiviral therapy
Betacoronavirus
caused
cholesterol
cholesterol 25‐hydroxylase
concentrations
convert
Coronavirus disease 2019
COVID
deplete
depleting
effective
enzyme
Epidemics
globe
Host
Host immune response
human lung organoids
Infection
Infectious virus
inhibit
Innate immunity
ISG
lung epithelial cell
mechanism
membrane
Membrane & Intracellular Transport
membrane fusion
MERS
Microbiology, Virology & Host Pathogen Interaction
Middle East
other coronavirus
outbreak
pathogenic coronaviruses
patients
plasma membrane
provide
related virus
respiratory syndrome coronavirus
restriction factor of coronaviruses
Spread
subsequent
suppress
therapeutic
Toxicity
USA
Vaccine
viral disease
viral entry
viral fusion
viral membrane
viral pathogenesis
[DOI] 10.15252/embj.2020106057 PMC 바로가기 [Article Type] Article
[DOI] 10.15252/embj.2020106057 PMC 바로가기 [Article Type] Article
COVID-19 in Patient with Sarcoidosis Receiving Long-Term Hydroxychloroquine Treatment, France, 2020
Research Letter
[키워드] 2019 novel coronavirus disease
adequate plasma
concentrations
coronavirus
coronavirus disease
COVID-19
curative treatment
evaluated
France
Hydroxychloroquine
hydroxychloroquine treatment
In vitro studies
Patient
plasma concentration
Postexposure Prophylaxis
receiving
respiratory infections
sarcoidosis
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
viruses
zoonoses
[DOI] 10.3201/eid2610.201816 PMC 바로가기 [Article Type] Research Letter
[DOI] 10.3201/eid2610.201816 PMC 바로가기 [Article Type] Research Letter